ClinPharm Consulting has changed its name to Kinetigen, Inc., effective February 1, 2013. All management, scientific, and operational components of Kinetigen will remain the same as under ClinPharm, including the consulting firm’s focus on clinical pharmacology and pharmacokinetics. The change reflects the company’s expanded role in the pharmaceutical industry and its evolution into clinical pharmacology and pharmacokinetics consulting firm.  
 
“I’m thrilled to continue to build upon ClinPharm Consulting’s reputation and consultancy under our new name of Kinetigen,” said Geoffrey Banks, Ph.D., Kinetigen president and chief executive officer. “The launch of Kinetigen is the keystone of our strategic growth initiative that will solidify our position as the go-to resource for clinical pharmacology and pharmacokinetics in the pharmaceutical industry.”
 
“All of our services remain the same with the transition to Kinetigen,” said Bill Wargin, Ph.D., Kinetigen executive vice president and chief scientific officer. “We have enhanced our SOPs and working practices, implemented more quality control procedures, and strengthened our training processes to ensure the highest quality product and services continue under Kinetigen that our clients have come to expect.”